Form 4 for MNKD MANNKIND CORP
Accepted 2024-02-05 00:00:00 ET · period of report 2023-12-31 · accession 0001209191-24-002743 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2024-02-05 | 2023-12-31+ | MNKD | BLANK BURKHARD | EVP Chief Medical Off | A - Grant | $3.26 | +157.9K | 367.9K | +75% | +$515.4K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, $0.01 Par Value | 2023-12-31 | A | A | 5,000 | $3.09 | 215,000 | D | — | — | |
| 2 | Common | Common Stock, $0.01 Par Value | 2024-02-04 | A | A | 152,905 | $3.27 | 367,905 | D | — | — |